{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:33:09Z","timestamp":1782901989497,"version":"3.54.5"},"reference-count":129,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1988,5,1]],"date-time":"1988-05-01T00:00:00Z","timestamp":578448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[1988,5]]},"DOI":"10.1097\/00000441-198805000-00014","type":"journal-article","created":{"date-parts":[[2006,9,29]],"date-time":"2006-09-29T08:51:10Z","timestamp":1159519870000},"page":"478-496","source":"Crossref","is-referenced-by-count":14,"title":["Southwestern Internal Medicine Conference: Molecular Mechanisms of Autoimmunity"],"prefix":"10.1016","volume":"295","author":[{"given":"J. Donald","family":"Smiley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Sterling E.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/00000441-198805000-00014_bb0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1984.tb00484.x","article-title":"Idiotypic networks and other preconceived ideas","volume":"79","author":"Jerne","year":"1984","journal-title":"Immunol Rev"},{"key":"10.1097\/00000441-198805000-00014_bb0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1749-6632.1986.tb20852.x","article-title":"Molecular genetics and T cells in autoimmunity","volume":"475","author":"Stastny","year":"1986","journal-title":"Ann NY Acad Sci"},{"key":"10.1097\/00000441-198805000-00014_bb0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/path.1711500103","article-title":"Class II major histocompatibility complex and organ specific autoimmunity in man","volume":"150","author":"Foulis","year":"1986","journal-title":"J Pathol"},{"key":"10.1097\/00000441-198805000-00014_bb0025","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1126\/science.2433769","article-title":"Immunological seif, nonself discrimination","volume":"235","author":"Guillet","year":"1987","journal-title":"Science"},{"key":"10.1097\/00000441-198805000-00014_bb0030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-3-642-82480-7_3","article-title":"Cellular differentiation of lymphoid subpopulations and their micro-environments in the human thymus","volume":"75","author":"Janossy","year":"1986","journal-title":"Curr Top Pathol"},{"key":"10.1097\/00000441-198805000-00014_bb0035","first-page":"439","article-title":"The human thymus microenvironment: In vivo Identification of thymic nurse cells and other antigenieally-distinet subpopulations of epithelial cells","volume":"44","author":"Ritter","year":"1981","journal-title":"Immunology"},{"key":"10.1097\/00000441-198805000-00014_bb0040","doi-asserted-by":"crossref","first-page":"7008","DOI":"10.1073\/pnas.83.18.7008","article-title":"Selective Inhibition of interleukin 2 gene function following thymocyte antigen\/major histocompatibility complex receptor crosslinking: possible thymic selection mechanism","volume":"83","author":"Ramarli","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1097\/00000441-198805000-00014_bb0045","series-title":"Adv Intern Med 31","first-page":"1","article-title":"The T cell circuit: clinical and biological implications","author":"Romain","year":"1986"},{"key":"10.1097\/00000441-198805000-00014_bb0050","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.4049\/jimmunol.136.6.1945","article-title":"Regulation of the alternative pathway of T cell activation by anti-T3 monoclonal antibody","volume":"136","author":"Fox","year":"1986","journal-title":"J Immunol"},{"key":"10.1097\/00000441-198805000-00014_bb0055","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.4049\/jimmunol.136.6.1951","article-title":"An autoreactive T cell clone that can be activated to provide both helper and suppressor function","volume":"136","author":"Kotani","year":"1986","journal-title":"J Immunol"},{"key":"10.1097\/00000441-198805000-00014_bb0060","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/eji.1830161119","article-title":"T lymphocyte control of autoreactivity: analysis with human T cell clones and limiting dilution culture","volume":"16","author":"Deusch","year":"1986","journal-title":"Eur J Immunol"},{"key":"10.1097\/00000441-198805000-00014_bb0065","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0308-2261(82)80013-1","article-title":"Enzyme patterns in normal lymphocyte subpopulations, lymphoid leukaemias and immunodeficiency Syndromes","volume":"11","author":"Hoflbrand","year":"1982","journal-title":"Clin Haematol"},{"key":"10.1097\/00000441-198805000-00014_bb0070","first-page":"387","article-title":"Immunoglobulin synthesis in vitro by human thymus: comparison of myasthenia gravis and normal thymus","volume":"4","author":"Smiley","year":"1969","journal-title":"Clin Exp Immunol"},{"key":"10.1097\/00000441-198805000-00014_bb0075","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1126\/science.140.3572.1218","article-title":"Individual antigenic specificity of isolated antibodies","volume":"140","author":"Kunkel","year":"1963","journal-title":"Science"},{"key":"10.1097\/00000441-198805000-00014_bb0080","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1146\/annurev.iy.01.040183.003033","article-title":"Genetics, expression and function ofidiotypes","volume":"1","author":"Rajewsky","year":"1983","journal-title":"Annu Rev Immunol"},{"key":"10.1097\/00000441-198805000-00014_bb0085","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1600-065X.1984.tb00489.x","article-title":"Mechanism of neonatally induced idiotype suppression and its relevance for the acquisition of self-tolerance","volume":"79","author":"Takemori","year":"1984","journal-title":"Immunol Rev"},{"key":"10.1097\/00000441-198805000-00014_bb0090","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0167-5699(81)90020-7","article-title":"Immunological studies of hormone receptors: a two-way approach","volume":"2","author":"Strosberg","year":"1981","journal-title":"Immunology Today"},{"key":"10.1097\/00000441-198805000-00014_bb0095","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/290293a0","article-title":"Idiotype restriction in myasthenia gravis antibodies","volume":"290","author":"Vincent","year":"1981","journal-title":"Nature"},{"key":"10.1097\/00000441-198805000-00014_bb0100","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/305056a0","article-title":"Monoclonal antibodies to the acetylcholine receptor by a normally functioning auto-anti-idiotypic mechanism","volume":"305","author":"Cleveland","year":"1983","journal-title":"Nature"},{"key":"10.1097\/00000441-198805000-00014_bb0105","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/08820138609026688","article-title":"Anti-idiotypic antibodies and disease","volume":"15","author":"Monroe","year":"1986","journal-title":"Immunol Invest"},{"key":"10.1097\/00000441-198805000-00014_bb0110","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/08820138609026689","article-title":"New concepts in autoimmunity","volume":"15","author":"Zanetti","year":"1986","journal-title":"Immunol Invest"},{"key":"10.1097\/00000441-198805000-00014_bb0115","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4049\/jimmunol.138.1.7","article-title":"Generation of idiotypic and anti-idiotypic antibodies by immunization with peptides encoded by complementary RNA: a possible molecular basis for the network theory","volume":"138","author":"Smith","year":"1987","journal-title":"J Immunol"},{"key":"10.1097\/00000441-198805000-00014_bb0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0307-742X(21)00618-4","article-title":"Connective tissue disease in the elderly","volume":"12","author":"Stevens","year":"1986","journal-title":"Clin Rheum Dis"},{"key":"10.1097\/00000441-198805000-00014_bb0125","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.4049\/jimmunol.135.4.2393","article-title":"Genetic restriction of autoreactive acetylcholine receptor-specific T lymphocytes in myasthenia gravis","volume":"135","author":"Hohlfeld","year":"1985","journal-title":"J Immunol"},{"key":"10.1097\/00000441-198805000-00014_bb0130","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1749-6632.1981.tb33745.x","article-title":"Autoantibodies and HLA antigens in ocular, generalized and penicillamine-induced myasthenia gravis","volume":"377","author":"Dawkins","year":"1981","journal-title":"Ann NY Acad Sci"},{"key":"10.1097\/00000441-198805000-00014_bb0135","doi-asserted-by":"crossref","first-page":"887","DOI":"10.4049\/jimmunol.136.3.887","article-title":"Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis","volume":"136","author":"Fuji","year":"1986","journal-title":"J Immunol"},{"key":"10.1097\/00000441-198805000-00014_bb0140","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1212\/WNL.36.5.618","article-title":"Myasthenia gravis: Stimulation of antireceptor autoantibodies by autoreactive T cell lines","volume":"36","author":"Hohlfeld","year":"1986","journal-title":"Neurology"},{"key":"10.1097\/00000441-198805000-00014_bb0145","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0165-2478(86)90101-X","article-title":"Epstein-Barr virus-transformed B cells can present acetylcholine receptor to autologous autoreactive T cells","volume":"12","author":"Hohlfeld","year":"1986","journal-title":"Immunol Lett"},{"key":"10.1097\/00000441-198805000-00014_bb0150","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ana.410190119","article-title":"Suppressor T cells in myasthenia gravis and antibodies to acetylcholine receptor","volume":"19","author":"Lisak","year":"1986","journal-title":"Ann Neurol"},{"key":"10.1097\/00000441-198805000-00014_bb0155","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ana.410190314","article-title":"Effect of thymectomy on blood T-cell subsets in myasthenia gravis","volume":"19","author":"Cox","year":"1986","journal-title":"Ann Neurol"},{"key":"10.1097\/00000441-198805000-00014_bb0160","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/art.1780230414","article-title":"Penicillamine-induced myasthenia gravis in progressive systemic sclerosis","volume":"23","author":"Torres","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1097\/00000441-198805000-00014_bb0165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1172\/JCI111207","article-title":"Immunosuppression by D-penicillamine in vitro. Inhibition of human T-lymphocyte proliferation by copper or ceruloplasmin-dependent generation of hydrogen peroxide and protection by monocytes","volume":"73","author":"Lipsky","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1097\/00000441-198805000-00014_bb0170","first-page":"15","article-title":"D-Penicillamine: mecanisme d\u2019aetion cellulaire et maladies auto-immunes induites","volume":"53","author":"Meyer","year":"1986","journal-title":"Revue Rhumatism"},{"issue":"Suppl","key":"10.1097\/00000441-198805000-00014_bb0175","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/03009747909108234","article-title":"Influence of D-penicillamine treatment on the humoral immune System","volume":"28","author":"Stanworth","year":"1979","journal-title":"Scand J Rheumatol"},{"issue":"Suppl","key":"10.1097\/00000441-198805000-00014_bb0180","first-page":"56","article-title":"Immunobiology of D-penicillamine","volume":"7","author":"Dawkins","year":"1981","journal-title":"J Rheumatol"},{"key":"10.1097\/00000441-198805000-00014_bb0185","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.1.5958.600","article-title":"Myasthenia gravis associated with penicillamine treatment for rheumatoid arthritis","volume":"1","author":"Bucknall","year":"1975","journal-title":"Br Med J"},{"key":"10.1097\/00000441-198805000-00014_bb0190","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/bmj.2.5973.726-a","article-title":"Myasthenia Syndrome during penicillamine treatment for rheumatoid arthritis","volume":"2","author":"Czlonkowska","year":"1975","journal-title":"Br Med J"},{"key":"10.1097\/00000441-198805000-00014_bb0195","doi-asserted-by":"crossref","first-page":"578","DOI":"10.7326\/0003-4819-87-5-578","article-title":"D-penicillamine-induced myasthenia gravis in rheumatoid arthritis","volume":"87","author":"Gordon","year":"1977","journal-title":"Ann Intern Med"},{"key":"10.1097\/00000441-198805000-00014_bb0200","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1001\/jama.1980.03310160038022","article-title":"Myasthenia gravis and penicillamine therapy of rheumatoid arthritis","volume":"244","author":"Bocanegra","year":"1980","journal-title":"JAMA"},{"key":"10.1097\/00000441-198805000-00014_bb0205","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0002-9343(77)90153-X","article-title":"Penicillamine-associated myasthenia gravis, antiacetylcholine receptor and antistriational antibodies","volume":"63","author":"Masters","year":"1977","journal-title":"Am J Med"},{"key":"10.1097\/00000441-198805000-00014_bb0210","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1056\/NEJM198008073030602","article-title":"HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis","volume":"303","author":"Wooley","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1097\/00000441-198805000-00014_bb0215","first-page":"269","article-title":"Genetic markers in rheumatoid arthritis relationship to toxicity from D-penicillamine","volume":"13","author":"Stockman","year":"1986","journal-title":"J Rheumatol"},{"key":"10.1097\/00000441-198805000-00014_bb0220","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/bmj.286.6362.338","article-title":"HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis","volume":"286","author":"Garlepp","year":"1983","journal-title":"Br Med J"},{"key":"10.1097\/00000441-198805000-00014_bb0225","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/ard.42.5.500","article-title":"Penicillamine-induced myasthenia in rheumatoid arthritis: Its clinical and genetic features","volume":"42","author":"Delamere","year":"1983","journal-title":"Ann Rheum Dis"},{"key":"10.1097\/00000441-198805000-00014_bb0230","doi-asserted-by":"crossref","first-page":"699","DOI":"10.7326\/0003-4819-104-5-699","article-title":"The toxicity of D-penicillamine in systemic sclerosis","volume":"104","author":"Steen","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1097\/00000441-198805000-00014_bb0235","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1590\/S0004-282X1984000400010","article-title":"Myasthenia gravis induced by D-penicillamine in a patient with progressive systemic sclerosis","volume":"42","author":"Marchiori","year":"1984","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1097\/00000441-198805000-00014_bb0240","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0016-5085(84)90604-8","article-title":"D-penicillamine-induced myasthenia gravis in primary biliary cirrhosis","volume":"84","author":"Marcus","year":"1984","journal-title":"Gastroenterology"},{"key":"10.1097\/00000441-198805000-00014_bb0245","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/bmj.288.6412.192-a","article-title":"Penicillamine induced myasthenia reactivated by gold","volume":"288","author":"Moore","year":"1984","journal-title":"Br Med J"},{"key":"10.1097\/00000441-198805000-00014_bb0250","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1172\/JCI107057","article-title":"Lymphocytotoxin formation by lymphocytes and muscle in polymyositis","volume":"51","author":"Johnson","year":"1972","journal-title":"J Clin Invest"},{"key":"10.1097\/00000441-198805000-00014_bb0255","first-page":"309","article-title":"Human muscle-derived, tissue specific, myocytotoxic T-cell lines in dermatomyositis","volume":"67","author":"Rosenschein","year":"1987","journal-title":"Clin Exp Immunol"},{"key":"10.1097\/00000441-198805000-00014_bb0260","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1097\/00007611-198110000-00042","article-title":"Penicillamine-induced polymyositis in a patient with rheumatoid arthritis","volume":"74","author":"Fisher","year":"1976","journal-title":"South Med J"},{"key":"10.1097\/00000441-198805000-00014_bb0265","doi-asserted-by":"crossref","first-page":"327","DOI":"10.7326\/0003-4819-98-3-327","article-title":"Fatal polymyositis in D-penicillamine-treated rheumatoid arthritis","volume":"98","author":"Doyle","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1097\/00000441-198805000-00014_bb0270","first-page":"143","article-title":"Neuromuscular disorders associated with D-penicillamine treatment for rheumatoid arthritis","volume":"5","author":"Devogelaer","year":"1985","journal-title":"Int J Clin Pharmacol Res"},{"key":"10.1097\/00000441-198805000-00014_bb0275","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/art.1780290416","article-title":"D-penicillamine-induced polymyositis in patients with rheumatoid arthritis","volume":"29","author":"Takahashi","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1097\/00000441-198805000-00014_bb0280","first-page":"887","article-title":"D-penicillamine et dermatopolymyosite. Valeur de la recherche des anticorps anti-JO 1","volume":"15","author":"Oberlin","year":"1986","journal-title":"Presse Med"},{"key":"10.1097\/00000441-198805000-00014_bb0285","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0090-1229(86)90210-2","article-title":"Immune abnormalities associated with HLA-B8: lymphocyte subsets and functional correlates","volume":"39","author":"McCombs","year":"1986","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1097\/00000441-198805000-00014_bb0290","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJM198506273122604","article-title":"Systemic lupus erythematosus with deficiency of the T4 epitope on T helper\/ inducer cells","volume":"312","author":"Stohl","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1097\/00000441-198805000-00014_bb0295","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1126\/science.2990044","article-title":"A large deletion within the T cell receptor beta-chain gene complex in New Zealand White mice","volume":"229","author":"Kotzin","year":"1985","journal-title":"Science"},{"key":"10.1097\/00000441-198805000-00014_bb0300","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1084\/jem.163.3.644","article-title":"Delineation of a defect in T cell receptor beta genes of NZB mice predisposed to autoimmunity","volume":"163","author":"Noonan","year":"1986","journal-title":"J Exp Med"},{"key":"10.1097\/00000441-198805000-00014_bb0305","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.1073\/pnas.83.18.7018","article-title":"Clonal diversity and T cell receptor beta-chain variable gene expression in enlarged lymph nodes of MRL-lpr\/lpr lupus mice","volume":"83","author":"Singer","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1097\/00000441-198805000-00014_bb0310","doi-asserted-by":"crossref","first-page":"7865","DOI":"10.1073\/pnas.83.20.7865","article-title":"T-cell antigen-receptor genes in autoimmune mice","volume":"83","author":"Hashimoto","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1097\/00000441-198805000-00014_bb0315","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1172\/JCI111261","article-title":"Relationship between systemic lupus erythematosus T cell subsets, anti-T cell antibodies, and T cell functions","volume":"73","author":"Morimoto","year":"1983","journal-title":"J Clin Invest"},{"key":"10.1097\/00000441-198805000-00014_bb0320","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/art.1780290509","article-title":"Effect of anti-T cell autoantibodies from systemic lupus erythematosus sera upon T lymphocyte functions","volume":"29","author":"Goldschmidt","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1097\/00000441-198805000-00014_bb0325","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.4049\/jimmunol.136.9.3246","article-title":"Modulation of IgM antilymphocyte antibody-reactive T cell surface antigens in systemic lupus erythematosus","volume":"136","author":"Winfield","year":"1986","journal-title":"J Immunol"},{"key":"10.1097\/00000441-198805000-00014_bb0330","first-page":"8","article-title":"Systemic lupus erythematosus sera antilymphocyte reactivity: detection of antibodies to Tac-antigen positive T cell lines","volume":"63","author":"Sano","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"10.1097\/00000441-198805000-00014_bb0335","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4049\/jimmunol.134.1.187","article-title":"Characterization of T lymphocyte subpopulations responsible for deficient Interleukin 2 activity in patients with systemic lupus erythematosus","volume":"134","author":"Murakawa","year":"1985","journal-title":"J Immunol"},{"key":"10.1097\/00000441-198805000-00014_bb0340","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1172\/JCI111758","article-title":"Correction of interleukin-2 production in patients with systemic lupus erythematosus by removal of spontaneously activated suppressor cells","volume":"75","author":"Linker-Israeli","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1097\/00000441-198805000-00014_bb0345","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.4049\/jimmunol.137.11.3515","article-title":"The interleukin 2 secretion defect in vitro in systemic lupus erythematosus is reversible in rested cultured T cells","volume":"137","author":"Huang","year":"1986","journal-title":"J Immunol"},{"key":"10.1097\/00000441-198805000-00014_bb0350","first-page":"508","article-title":"B cell activity and regulatory T cell function in systemic lupus erythematosus by human B cell colony formation","volume":"12","author":"Otsuka","year":"1985","journal-title":"JRheumatol"},{"key":"10.1097\/00000441-198805000-00014_bb0355","first-page":"598","article-title":"Stimulating and differentiating factors for human B lymphocytes in systemic lupus erythematosus","volume":"65","author":"Martinez-Cordero","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"10.1097\/00000441-198805000-00014_bb0360","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.4049\/jimmunol.137.12.3809","article-title":"Deficiencies in suppressor T cell activity seen in patients with active systemic lupus erythematosus are due to the dilution of normally functioning suppressor T cells by nonsuppressor T cells","volume":"137","author":"Sakane","year":"1986","journal-title":"J Immunol"},{"key":"10.1097\/00000441-198805000-00014_bb0365","first-page":"80","article-title":"T cell function in systemic lupus erythematosus: normal production of and responsiveness to interleukin 2","volume":"64","author":"Draeger","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"10.1097\/00000441-198805000-00014_bb0370","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0090-1229(86)90012-7","article-title":"Suppressor cell function and anti-DNA antibody idiotypes in the serum of SLE patients and their first-degree relatives","volume":"41","author":"Schattner","year":"1986","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1097\/00000441-198805000-00014_bb0375","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4049\/jimmunol.138.1.123","article-title":"A monoclonal antibody to a cross-reactive idiotype on cationic human anti-DNA antibodies expressing lambda light chains: A new reagent to identify a potentially differential pathogenic subset","volume":"138","author":"Livneh","year":"1987","journal-title":"J Immunol"},{"key":"10.1097\/00000441-198805000-00014_bb0380","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/ki.1986.223","article-title":"Monoclonal antibody Identification of infiltrating mononuclear leukocytes in lupus nephritis","volume":"30","author":"D\u2019Agati","year":"1986","journal-title":"Kidney Int"},{"key":"10.1097\/00000441-198805000-00014_bb0385","first-page":"185","article-title":"HLA-DR + T cells of the Leu 3 (helper) type infiltrate the kidneys of patients with systemic lupus erythematosus","volume":"59","author":"Caligaris-Cappio","year":"1985","journal-title":"Clin Exp Immunol"},{"key":"10.1097\/00000441-198805000-00014_bb0390","series-title":"Advances in Nephrology","first-page":"333","article-title":"Atypical lupus with special reference to ANA negative lupus and lupus subsets","author":"Hughes","year":"1985"},{"key":"10.1097\/00000441-198805000-00014_bb0395","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00000441-198507000-00007","article-title":"Southwestern Internal Medicine Conference: Drug-induced lupus: clinical spectrum and pathogenesis","volume":"290","author":"Cush","year":"1985","journal-title":"Am J Med Sci"},{"key":"10.1097\/00000441-198805000-00014_bb0400","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/00325481.1985.11699121","article-title":"Drug-induced lupus. Genetic, clinical and laboratory features","volume":"78","author":"Totoritis","year":"1985","journal-title":"Postgrad Med"},{"key":"10.1097\/00000441-198805000-00014_bb0405","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/00325481.1985.11698908","article-title":"Drug-induced systemic lupus. Differentiating it from the real thing","volume":"77","author":"Kaie","year":"1985","journal-title":"Postgrad Med"},{"key":"10.1097\/00000441-198805000-00014_bb0410","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0014-5793(85)80631-1","article-title":"Hydralazine binds covalently to complement component C4, different reactivity of C4A and C4B gene products","volume":"184","author":"Sim","year":"1985","journal-title":"FEBS Lett"},{"key":"10.1097\/00000441-198805000-00014_bb0415","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0165-2478(85)90011-2","article-title":"Hydrazine and isoniazid reduce the formation of soluble immune complexes by complement","volume":"9","author":"Schifferli","year":"1985","journal-title":"Immunol Lett"},{"key":"10.1097\/00000441-198805000-00014_bb0420","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0190-9622(86)80432-7","article-title":"Hydrazine derivatives and induction of systemic lupus erythematosus","volume":"14","author":"Pereyo","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1097\/00000441-198805000-00014_bb0425","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/ard.45.9.771","article-title":"Pulmonary hypertension in hydralazine induced systemic lupus erythematosus: association with C4 null allele","volume":"45","author":"Asherson","year":"1986","journal-title":"Ann Rheum Dis"},{"key":"10.1097\/00000441-198805000-00014_bb0430","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(80)91554-8","article-title":"Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility","volume":"1","author":"Batchelor","year":"1980","journal-title":"Lancet"},{"key":"10.1097\/00000441-198805000-00014_bb0435","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0002-9343(86)90653-4","article-title":"Serologie changes during induction of lupus-like disease by procainamide","volume":"80","author":"Rubin","year":"1986","journal-title":"Am J Med"},{"key":"10.1097\/00000441-198805000-00014_bb0440","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/archinte.1985.00360040132028","article-title":"Thrombocytopenia following sustained-release procainamide","volume":"145","author":"Meisner","year":"1985","journal-title":"Arch Intern Med"},{"key":"10.1097\/00000441-198805000-00014_bb0445","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0049-0172(85)90012-5","article-title":"Quinidine-induced lupus syndrome","volume":"15","author":"McCormack","year":"1985","journal-title":"Semin Arthritis Rheum"},{"key":"10.1097\/00000441-198805000-00014_bb0450","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1001\/archinte.1985.00360030078017","article-title":"Systemic lupus erythematosus (SLE) induced by quinidine","volume":"145","author":"Lavie","year":"1985","journal-title":"Arch Intern Med"},{"key":"10.1097\/00000441-198805000-00014_bb0455","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1001\/archinte.1985.00360090216041","article-title":"Quinidine-induced lupus erythematosus","volume":"145","author":"Krainin","year":"1985","journal-title":"Arch Intern Med"},{"key":"10.1097\/00000441-198805000-00014_bb0460","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/0002-8703(86)90032-3","article-title":"Quinidine-induced lupus erythematosus","volume":"111","author":"Bar-El","year":"1986","journal-title":"Am Heart J"},{"key":"10.1097\/00000441-198805000-00014_bb0465","doi-asserted-by":"crossref","first-page":"419","DOI":"10.7326\/0003-4819-102-3-419_2","article-title":"Procainamide, quinidine, and lupus erythematosus","volume":"102","author":"Amadio","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1097\/00000441-198805000-00014_bb0470","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/bmj.291.6490.249","article-title":"Fatal exacerbation of systemic lupus erythematosus after treatment with griseofulvin","volume":"291","author":"Madhok","year":"1985","journal-title":"Br Med J"},{"key":"10.1097\/00000441-198805000-00014_bb0475","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2340\/0001555565447448","article-title":"Lupus erythematosus-like eruption from captopril","volume":"65","author":"Patri","year":"1985","journal-title":"Acta Derm Venereol"},{"key":"10.1097\/00000441-198805000-00014_bb0480","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/art.1780280109","article-title":"Effects of L-Canavanine on T cells may explain the induction of systemic lupus erythematosus by alfalfa","volume":"28","author":"Alcocer-Varela","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1097\/00000441-198805000-00014_bb0485","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/art.1780281022","article-title":"The mechanism of action of L-canavanine in inducing autoimmune phenomena","volume":"28","author":"Prete","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1097\/00000441-198805000-00014_bb0490","first-page":"726","article-title":"Reticuloendothelial System Fc receptor function in the drug induced lupus syndrome","volume":"13","author":"Fields","year":"1986","journal-title":"J Rheumatol"},{"issue":"Suppl","key":"10.1097\/00000441-198805000-00014_bb0495","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/03009748509102061","article-title":"Antinuclear antibodies in the immunotaxonomy of connective tissue diseases","volume":"56","author":"Maini","year":"1985","journal-title":"Scand J Rheumatol"},{"key":"10.1097\/00000441-198805000-00014_bb0500","first-page":"1","article-title":"Antinuclear antibodies in the investigation of rheumatic diseases","volume":"35","author":"Fritzler","year":"1985","journal-title":"Bull Rheum Dis"},{"key":"10.1097\/00000441-198805000-00014_bb0505","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/art.1780280209","article-title":"The diagnostic value of antihistone antibodies in drug-induced lupus erythematosus","volume":"28","author":"Epstein","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1097\/00000441-198805000-00014_bb0510","first-page":"304","article-title":"The clinical application of an ELISA technique for the detection of antihistone antibodies","volume":"13","author":"Epstein","year":"1986","journal-title":"J Rheumatol"},{"issue":"Suppl","key":"10.1097\/00000441-198805000-00014_bb0515","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3109\/03009748509102060","article-title":"Anti-histones","volume":"56","author":"Francoeur","year":"1985","journal-title":"Scand J Rheumatol"},{"key":"10.1097\/00000441-198805000-00014_bb0520","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0090-1229(85)90038-8","article-title":"IgG antibodies to the histone complex H2A-H2B characterize procainamide-induced lupus","volume":"36","author":"Rubin","year":"1985","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1097\/00000441-198805000-00014_bb0525","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.4049\/jimmunol.135.5.3116","article-title":"Antibodies from patients with drug-induced and idiopathic lupus erythematosus react with epitopes restricted to the amino and carboxyl termini of histone","volume":"135","author":"Gohill","year":"1985","journal-title":"J Immunol"},{"key":"10.1097\/00000441-198805000-00014_bb0530","doi-asserted-by":"crossref","first-page":"446","DOI":"10.4049\/jimmunol.138.2.446","article-title":"Anti-histone antibodies in idiopathic and drug-induced lupus recognize distinct intrahistone regions","volume":"138","author":"Portanova","year":"1987","journal-title":"J Immunol"},{"key":"10.1097\/00000441-198805000-00014_bb0535","doi-asserted-by":"crossref","first-page":"310","DOI":"10.7326\/0003-4819-104-3-310","article-title":"Anti-guanosine antibodies: a new marker for procainamide-induced systemic lupus erythematosus","volume":"104","author":"Weisbart","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1097\/00000441-198805000-00014_bb0540","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/art.1780280210","article-title":"The binding of antihistone antibodies to Crithidia luciliae kinetoplasts is growth cycle-dependent","volume":"28","author":"Deng","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1097\/00000441-198805000-00014_bb0545","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/bmj.287.6399.1088","article-title":"Thrombosis, abortion, cerebral disease, and the lupus anticoagulant","volume":"287","author":"Hughes","year":"1983","journal-title":"Br Med J"},{"key":"10.1097\/00000441-198805000-00014_bb0550","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1056\/NEJM198507183130304","article-title":"Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus","volume":"313","author":"Lockshin","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1097\/00000441-198805000-00014_bb0555","first-page":"449","article-title":"Anti-phospholipid antibodies in syphilis and a thrombotic subset of SLE: distinct profiles of epitope specificity","volume":"59","author":"Colaco","year":"1985","journal-title":"Clin Exp Immunol"},{"key":"10.1097\/00000441-198805000-00014_bb0560","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1001\/archinte.1985.00360100200038","article-title":"Lupus anticoagulant in drug-induced systemic lupus erythematosus (SLE)","volume":"145","author":"Gastineau","year":"1985","journal-title":"Arch Intern Med"},{"key":"10.1097\/00000441-198805000-00014_bb0565","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/art.1780291021","article-title":"Discordant effects of prednisone on anticardiolipin antibodies and the lupus anticoagulant","volume":"29","author":"Derksen","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1097\/00000441-198805000-00014_bb0570","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/art.1780291020","article-title":"Antibodies to cardiolipin and vascular complications in women taking oral contraceptives","volume":"29","author":"Bruneau","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1097\/00000441-198805000-00014_bb0575","first-page":"1","article-title":"Genetic control of the susceptibility to infection with pathogenic bacteria","volume":"124","author":"Zabriskie","year":"1986","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1097\/00000441-198805000-00014_bb0580","series-title":"Clinical Cardiology","first-page":"248","article-title":"Rheumatic fever, Collagen disease and the heart","author":"Smiley","year":"1977"},{"key":"10.1097\/00000441-198805000-00014_bb0585","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0140-6736(86)90004-8","article-title":"Evidence for an HLA-DR4-associated immune response gene for mycobacterium tuberculosis. A clue to the pathogenesis of rheumatoid arthritis?","volume":"2","author":"Ottenhoff","year":"1986","journal-title":"Lancet"},{"key":"10.1097\/00000441-198805000-00014_bb0590","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(86)90003-6","article-title":"T lymphocytes of rheumatoid arthritis patients show augmented reactivity to a fraction of mycobacteria cross-reactive with cartilage","volume":"2","author":"Holoshitz","year":"1986","journal-title":"Lancet"},{"key":"10.1097\/00000441-198805000-00014_bb0595","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1073\/pnas.79.19.6047","article-title":"Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiency","volume":"79","author":"Reinherz","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1097\/00000441-198805000-00014_bb0600","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/00007890-198336060-00005","article-title":"Treatment of acute renal allograft rejection with monoclonal anti-T12 (CD6) antibody","volume":"36","author":"Kirkman","year":"1983","journal-title":"Transplantation"},{"key":"10.1097\/00000441-198805000-00014_bb0605","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-106-2-257","article-title":"Immune interventions in disease","volume":"106","author":"Fahey","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1097\/00000441-198805000-00014_bb0610","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1445-5994.1985.tb04018.x","article-title":"Gold-induced bone marrow aplasia: successful treatment with antithymocyte globulin","volume":"15","author":"McGirr","year":"1985","journal-title":"Aust NZ J Med"},{"key":"10.1097\/00000441-198805000-00014_bb0615","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1749-6632.1986.tb20879.x","article-title":"Cyclosporine as a new approach to therapy of autoimmune diseases","volume":"475","author":"Borei","year":"1986","journal-title":"Ann NY Acad Sci"},{"key":"10.1097\/00000441-198805000-00014_bb0620","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00915009","article-title":"The effect of cyclosporine on immunization with tetanus and keyhole limpet hemocyanin (KLH) in humans","volume":"5","author":"Palestine","year":"1985","journal-title":"J Clin Immunol"},{"key":"10.1097\/00000441-198805000-00014_bb0625","first-page":"266","article-title":"Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset","volume":"49","author":"Vincent","year":"1982","journal-title":"Clin Exp Immunol"},{"key":"10.1097\/00000441-198805000-00014_bb0630","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4049\/jimmunol.138.2.407","article-title":"Analysis of immune complexes in rheumatoid arthritis for Epstein-Barr virus antigens reveals cross-reactivity of viral capsid antigen and human IgG","volume":"138","author":"Inman","year":"1987","journal-title":"J Immunol"},{"key":"10.1097\/00000441-198805000-00014_bb0635","series-title":"Arthritis Models and Mechanisms","first-page":"24","article-title":"Arthropathie properties of peptidoglycan Polysaccharide complexes of microbial origin","author":"Cromartie","year":"1981"},{"key":"10.1097\/00000441-198805000-00014_bb0640","first-page":"137","article-title":"Antigen specific suppressor T cells from chronic active hepatitis B virus (HBV) carriers inhibit the responsiveness to HBsAg of allogeneic high-responder lymphocytes","volume":"16","author":"Barnaba","year":"1985","journal-title":"J Clin Lab Immunol"},{"key":"10.1097\/00000441-198805000-00014_bb0645","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1600-0676.1986.tb00267.x","article-title":"Characterization of effector cells in lymphocytotoxicity to autologous hepatocytes in HBsAg-positive and autoimmune chronic active hepatitis (CAH)","volume":"6","author":"Barnaba","year":"1986","journal-title":"Liver"},{"key":"10.1097\/00000441-198805000-00014_bb0650","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-3083.1985.tb01910.x","article-title":"HLA control, of the proliferative T-lymphocyte response to antigenic deterrriinants on mumps virus. Studies of healthy individuals and patients with type 1 diabetes","volume":"22","author":"Bruserud","year":"1985","journal-title":"Scand J Immunol"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915365538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915365538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T19:00:49Z","timestamp":1707246049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962915365538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,5]]},"references-count":129,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1988,5]]}},"alternative-id":["S0002962915365538"],"URL":"https:\/\/doi.org\/10.1097\/00000441-198805000-00014","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[1988,5]]}}}